member_id: MBR2022000059
age: 77
gender: F
metal_level: silver
enrollment_months: 12
model_year: '2024'
prediction_year: null
benefit_year: 2024
risk_score: 14.588
input_icd10_codes:
- L00
input_ndc_codes:
- 00002418230
hcc_pipeline:
  raw_ccs:
  - '219'
  hccs_after_hierarchy:
  - '219'
  hccs_filtered:
  - '219'
  remaining_hccs:
  - '219'
  triggered_groups: []
  hcc_cnt: 1
rxc_pipeline:
  raw_rxcs:
  - '9'
  rxcs_after_hierarchy: &id001
  - '9'
edf:
  edf_variable: null
  edf_factor: 0.0
hcc_list:
- '219'
rxc_list: *id001
components:
- component_type: demographic
  component_code: FAGE_LAST_60_GT
  description: null
  coefficient: 0.271
  source_data:
  - age=77
  - gender=F
  superseded_by: null
  supersedes: []
  grouped_into: null
  table_references:
    table: table_9
    model: Adult
    metal_level: silver
- component_type: hcc
  component_code: HHS_HCC219
  description: Major Skin Burn or Condition
  coefficient: 2.759
  source_data:
  - L00
  superseded_by: null
  supersedes: []
  grouped_into: null
  table_references:
    icd_mapping: table_3
    hierarchy: table_4
    coefficient: table_9
    model: Adult
    metal_level: silver
- component_type: rxc
  component_code: RXC_09
  description: Immune suppressants and Immunomodulators
  coefficient: 11.558
  source_data:
  - 00002418230
  superseded_by: null
  supersedes: []
  grouped_into: null
  table_references:
    ndc_mapping: table_10a
    hierarchy: table_11
    coefficient: table_9
    model: Adult
    metal_level: silver
